AEON Biopharma, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
AEON on NYSE
Location
5 Park Plaza, Suite 1750, Irvine, CA

Insiders trading volume in the past year

AEON Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Priveterra Sponsor, LLC 10%+ Owner $139M Jul 21, 2023
Strathspey Crown Holdings Group, LLC 10%+ Owner $20.3M Aug 11, 2023
Jost Fischer Director $130K +$84.6K +186% May 21, 2025
Robert E. Bancroft President & CEO, Director $72.6K May 14, 2025
Seongsoo Park Director Apr 12, 2024
Alexander Wilson Exec VP, CLO & Corp Secretary May 21, 2025
Palmisano Robert J Director May 21, 2025
Marc Forth Director May 21, 2025
Chad Oh Chief Medical Officer May 21, 2025
Eric G. Carter Director May 21, 2025
Jennifer Sy Chief Accounting Officer May 21, 2025
Shelley B. Thunen Director May 21, 2025
Daewoong Co., Ltd 10%+ Owner Apr 12, 2024
Peter A. Reynolds Chief Financial Officer Jul 21, 2023
Barclays Plc 10%+ Owner Feb 20, 2023

Recent Insider Transactions by Companies or Individuals for AEON Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.